Search

everythinglearnresearchcommunity

for

Search:↓

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

The research found specific genes and proteins that affect how fast chickens' feathers grow, which is not solely determined by traditional inheritance patterns.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Combination therapies might work better for some vitiligo patients, but results vary.

Hair is important for aging and cancer treatment, affecting emotions, culture, and health.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.